ListedMainboard

Honasa Consumer Limited

HONASA31 Oct 2023 – 2 Nov 2023INE0J5401028
On listing day it
—
we hold no exchange bar dated on the listing date
Since then, against the issue price
+33.1%
₹431.35 on 30 Sept 2026

Against an issue price of ₹324. Split- and bonus-adjusted official closes — a past move, never a forecast.

Issue price
₹324
final issue price
Issue size
—
Lot size
46 sh
₹14,904 a lot
Listed on
7 Nov 2023
NSE
Now trading as HONASA — see its filed financials and price history →
Notes

Honasa Consumer Limited was a mainboard initial public offer.

The book was open from 31 October 2023 to 2 November 2023.

The issue was priced at ₹324 a share, from a band of ₹308 to ₹324.

We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.

The shares listed on 7 November 2023.

The last official close on file is ₹431 (30 September 2026), which is 33.1% above the issue price.

It now trades as HONASA, and its filed financials are on its company page.

How it has done since listing
NSE close · 30 Sept 2026
Issue price
₹324
final issue price
Listing-day move
—
Now vs issue price
+33.1%
30 Sept 2026
Since first close
—

Shares sold in the issue at ₹324 last closed at ₹431.35.

See HONASA’s filed financials and price history →

Official exchange closes, restated for splits, bonuses and rights issues since listing. A record of past price movement, not a forecast.

The offer
Issue price
₹324
face value ₹10
Lot size
46 sh
₹14,904 a lot
Registrar
KFin Technologies Limited (formerly known as KFin Technologies Private Limited)
Lead managers
  • Kotak Mahindra Capital Company
  • Citigroup Global Markets India Private Limited
  • JM Financial Limited
  • J.P. Morgan India Private Limited
What happens when
3-day book
  1. Bidding opens31 Oct 2023
  2. Bidding closes2 Nov 2023
  3. Basis of allotmentnot published

    Not published in the exchange feeds we ingest — we do not estimate it.

  4. Listing7 Nov 2023
Subscription

We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.

Demand at each price

We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.

Anchor investors

We have not extracted an anchor allotment list for this issue.

When locked shares come free
computed from ICDR rules
  • All other pre-issue capital
    SEBI ICDR 2018 Reg. 17 — all other pre-issue capital, 6 months from allotment
    7 May 2024
    already free
  • Promoters' minimum contribution
    SEBI ICDR 2018 Reg. 16(1)(a) — promoters' minimum contribution, 18 months from allotment
    7 May 2025
    already free

Computed from the SEBI ICDR 2018 lock-in rules, not disclosed by the issuer or the exchange. The regulation counts from the date of allotment, which no feed we ingest publishes, so these are counted from the listing date and fall at most two to three business days later than the true expiry.

How the price was set
as printed in the prospectus

Every offer document must set out the reasoning behind its own price: what the company earned in the years before it came to market, and what multiple of those earnings it is asking for. This is that chapter — the issuer’s argument for its price, not our assessment of it.

Asking, at the top of the band
—
The issuer's chosen peers
53.6x
average of a 25.7x – 83.1x range
Earnings the price leans on
₹-18.55
diluted, per share
Earnings per share, by year
YearBasicDilutedWeight
FY2021₹-98.35₹-98.351
FY2022₹0.53₹0.522
FY2023₹-4.66₹-4.663

Figures as printed in the offer document's "Basis for Offer Price" chapter. A record of the case the issuer made for its own price, not our valuation of it.

Restated financials

Everything we extracted from this issue's offer document is the pricing justification rather than the restated statements — it is shown under how the offer was priced. The restated financial statements themselves have not been extracted for this issue.

Objects of the offer

We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.

Who the issuer compares itself to
as printed in the offer document

The offer document must name the listed companies the issuer considers comparable, and print their valuation figures beside its own. This is that list — the issuer’s choice of comparison, not ours.

CompanyP/ERoNW
Colgate Palmolive (India) Limited54.361.0%
Hindustan Unilever Limited59.220.1%
Procter & Gamble Hygiene and Health Care Limited83.171.7%
The issuer’s own figures, as it printed them
EPS
₹-4.66
NAV per share
₹19.27
Return on net worth
-23.57%

The issuer's own figures as printed at the head of the same table — its claim about itself, on the same basis as its claims about the companies below.

Figures as PRINTED by the issuer in its own offer document. The comparison set is the issuer's choice, not ours.

Who ran this issue, and what else they have run
past issues only
Lead managers
FirmIssuesTypical listing move
Citigroup Global Markets
2022 – 2026
25
2 measurable
+1.2%
JM Financial Limited
2021 – 2026
71
19 measurable
+11.1%
J. P. Morgan India Private Limited
2022 – 2026
23
4 measurable
+2.6%
Kotak Mahindra Capital Company
2021 – 2026
65
15 measurable
+16.6%
Registrar
FirmIssuesTypical listing move
Kfin Technologies Limited
2021 – 2026
130
37 measurable
+6.5%

A count of what happened to the other issues each firm was named on, computed from exchange closes. Not a rating, not a ranking, and not a view on the firm.

Read the offer documents
2 filed

Filed with SEBI and the exchanges by the issuer. These are the source for every figure on this page.

Compiled from NSE and SEBI offer documents and exchange feeds. A description of the issue and of the bids received — not investment advice, and not a view on whether to apply. No grey-market premium, no allotment lookup and no listing-gain estimate is published here.